Crescent Biopharma Announces Grants of Inducement Awards
Crescent Biopharma granted options to purchase 23,550 shares to two non-executive employees as equity inducement awards. The options carry a 10-year term and an exercise price of $17.57, which matched the Nasdaq closing price on the grant date of June 10, 2026.
Key figures
- Term years
- 10
- Exercise price
- 17.57
- Shares granted
- 23550
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.